ERBB2 and breast carcinoma: Triple-negative breast cancer (TNBC) is a high-grade and aggressive breast cancer and often results in high patient mortality because these cancer cells do not express the estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2) [14].